Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 12138* | 2015 |
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 7836 | 2016 |
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 6894 | 2017 |
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5575 | 2015 |
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5323 | 2016 |
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 3703* | 2015 |
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial C Davies, H Pan, J Godwin, R Gray, R Arriagada, V Raina, M Abraham, ... The Lancet 381 (9869), 805-816, 2013 | 2425 | 2013 |
The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states AH Mokdad, K Ballestros, M Echko, S Glenn, HE Olsen, E Mullany, A Lee, ... Jama 319 (14), 1444-1472, 2018 | 1374 | 2018 |
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1290 | 2017 |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1256 | 2013 |
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 CJL Murray, KF Ortblad, C Guinovart, SS Lim, TM Wolock, DA Roberts, ... The Lancet 384 (9947), 1005-1070, 2014 | 1255 | 2014 |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 1224 | 2017 |
Cancer incidence in Egypt: results of the national population-based cancer registry program AS Ibrahim, HM Khaled, NNH Mikhail, H Baraka, H Kamel Journal of cancer epidemiology 2014, 2014 | 1065 | 2014 |
International variation in female breast cancer incidence and mortality rates CE DeSantis, F Bray, J Ferlay, J Lortet-Tieulent, BO Anderson, A Jemal Cancer epidemiology, biomarkers & prevention 24 (10), 1495-1506, 2015 | 929 | 2015 |
Guideline implementation for breast healthcare in low‐income and middle‐income countries: Overview of the Breast Health Global Initiative Global Summit 2007 BO Anderson, CH Yip, RA Smith, R Shyyan, SF Sener, A Eniu, ... Cancer 113 (S8), 2221-2243, 2008 | 797 | 2008 |
The global breast cancer burden: variations in epidemiology and survival GN Hortobagyi, J de la Garza Salazar, K Pritchard, D Amadori, ... Clinical breast cancer 6 (5), 391-401, 2005 | 794 | 2005 |
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990 … GBD 2013 Risk Factors Collaborators Lancet (London, England) 386 (10010), 2287, 2015 | 758 | 2015 |
Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology WJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ... Journal of the National Comprehensive Cancer Network 18 (4), 452-478, 2020 | 738 | 2020 |
Trends in incidence rates of invasive lobular and ductal breast carcinoma CI Li, BO Anderson, JR Daling, RE Moe Jama 289 (11), 1421-1424, 2003 | 725 | 2003 |
Micrometastases or isolated tumor cells and the outcome of breast cancer M De Boer, CHM Van Deurzen, JAAM Van Dijck, GF Borm, PJ Van Diest, ... New England Journal of Medicine 361 (7), 653-663, 2009 | 659* | 2009 |